A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma
Abstract Background Colon cancer is the foremost reason of cancer-related mortality worldwide. Colon adenocarcinoma constitutes 90% of colon cancer, and most patients with colon adenocarcinoma (COAD) are identified until advanced stage. With the emergence of an increasing number of novel pathogenic...
Main Authors: | Hongli Gao, Fei Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Medical Informatics and Decision Making |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12911-022-02020-3 |
Similar Items
-
A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients
by: Kaili Chang, et al.
Published: (2021-03-01) -
Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma
by: Jianwei Lin, et al.
Published: (2022-09-01) -
High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma
by: Yixing Yang, et al.
Published: (2022-05-01) -
Construction of a prognostic model for colorectal adenocarcinoma based on Zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis
by: Hua Chen, et al.
Published: (2023-09-01) -
A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma
by: Fada Xia, et al.
Published: (2021-12-01)